Adapted for Calculate in partnership with London’s Thrombosis Research Institute, it's a recently validated tool that predicts the risk of mortality, ischemic stroke and major bleeding in atrial fibrillation patients being considered for anticoagulation.

Use it to compare 3 different anticoagulant treatment options: no anticoagulation, vitamin K antagonist, and non-vitamin K oral anticoagulant (NOAC).